Showing 1 - 20 results of 30,038 for search '(( 50 ((_ decrease) OR (a decrease)) ) OR ((( 500 mg decrease ) OR ( _ anc decrease ))))*', query time: 0.81s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

    Published 2019
    “…There was a trend toward decreased Ki67 staining in FTY720-treated tumors (p = 0.29). …”
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…<div><p>Background and Aim</p><p>Liver cirrhosis is associated with decreased hepatic cytochrome P4503A (CYP3A) activity but the pathogenesis of this phenomenon is not well elucidated. …”
  11. 11

    Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro. by David A. Davis (239142)

    Published 2009
    “…Curves represent mean change in optical density (OD) at 30-s intervals. (E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
  12. 12
  13. 13

    Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

    Published 2009
    “…<p>(A) RFF is decreased by alterations in heart rate. …”
  14. 14
  15. 15
  16. 16

    Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

    Published 2013
    “…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
  17. 17
  18. 18
  19. 19

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  20. 20